PMID- 33892086 OWN - NLM STAT- MEDLINE DCOM- 20211110 LR - 20231115 IS - 1878-5921 (Electronic) IS - 0895-4356 (Print) IS - 0895-4356 (Linking) VI - 137 DP - 2021 Sep TI - Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials. PG - 200-208 LID - S0895-4356(21)00118-9 [pii] LID - 10.1016/j.jclinepi.2021.04.002 [doi] AB - OBJECTIVE: Previous research on the minimal clinically important difference (MCID) for depression and anxiety is based on population averages. The present study aimed to identify the MCID across the spectrum of baseline severity. STUDY DESIGN AND SETTINGS: The present analysis used secondary data from 2 randomized controlled trials for depression (n = 1,122) to calibrate the Global Rating of Change with the PHQ-9 and GAD-7. The MCID was defined as a change in scores corresponding to a 50% probability of patients "feeling better", given their baseline severity, referred to as Effective Dose 50 (ED50). RESULTS: MCID estimates depended on baseline severity and ranged from no change for very mild up to 14 points (52%) on the PHQ-9 and up to 10 points (48%) on the GAD-7 for very high severity. The average MCID estimates were 3.7 points (23%) and 3.3 (28%) for the PHQ-9 and GAD-7 respectively. CONCLUSION: The ED50 method generates MCID estimates across the spectrum of baseline severity, offering greater precision but at the cost of greater complexity relative to population average estimates. This has important implications for evaluations of treatments and clinical practice where users can use these results to tailor the MCID to specific populations according to baseline severities. CI - Copyright (c) 2021. Published by Elsevier Inc. FAU - Bauer-Staeb, Clarissa AU - Bauer-Staeb C AD - Department of Psychology, University of Bath, Bath, United Kingdom. FAU - Kounali, Daphne-Zacharenia AU - Kounali DZ AD - Bristol Medical School, University of Bristol, Bristol, United Kingdom. FAU - Welton, Nicky J AU - Welton NJ AD - Bristol Medical School, University of Bristol, Bristol, United Kingdom. FAU - Griffith, Emma AU - Griffith E AD - Department of Psychology, University of Bath, Bath, United Kingdom; Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, United Kingdom. FAU - Wiles, Nicola J AU - Wiles NJ AD - Bristol Medical School, University of Bristol, Bristol, United Kingdom. FAU - Lewis, Glyn AU - Lewis G AD - Division of Psychiatry, University College London, London, United Kingdom. FAU - Faraway, Julian J AU - Faraway JJ AD - Department of Mathematical Sciences, University of Bath, Bath, United Kingdom. FAU - Button, Katherine S AU - Button KS AD - Department of Psychology, University of Bath, Bath, United Kingdom. Electronic address: k.s.button@bath.ac.uk. LA - eng SI - ISRCTN/ISRCTN84544741 SI - ISRCTN/ISRCTN38231611 GR - MR/K025643/1/MRC_/Medical Research Council/United Kingdom GR - MR/M005615/1/MRC_/Medical Research Council/United Kingdom GR - RP-PG-0610-10048/DH_/Department of Health/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210420 PL - United States TA - J Clin Epidemiol JT - Journal of clinical epidemiology JID - 8801383 SB - IM MH - Adult MH - Anxiety/*drug therapy/therapy MH - Depression/*drug therapy MH - Female MH - Humans MH - Male MH - Middle Aged MH - *Minimal Clinically Important Difference MH - Severity of Illness Index PMC - PMC8485844 OTO - NOTNLM OT - Clinically Meaningful Change OT - GAD-7 OT - MCID OT - Minimal Clinically Important Difference OT - PHQ-9 OT - Primary Care EDAT- 2021/04/24 06:00 MHDA- 2021/11/11 06:00 PMCR- 2021/09/01 CRDT- 2021/04/23 20:13 PHST- 2020/10/12 00:00 [received] PHST- 2021/03/24 00:00 [revised] PHST- 2021/04/13 00:00 [accepted] PHST- 2021/04/24 06:00 [pubmed] PHST- 2021/11/11 06:00 [medline] PHST- 2021/04/23 20:13 [entrez] PHST- 2021/09/01 00:00 [pmc-release] AID - S0895-4356(21)00118-9 [pii] AID - 10.1016/j.jclinepi.2021.04.002 [doi] PST - ppublish SO - J Clin Epidemiol. 2021 Sep;137:200-208. doi: 10.1016/j.jclinepi.2021.04.002. Epub 2021 Apr 20.